These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25406300)

  • 21. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial.
    Limalanathan S; Andersen GØ; Kløw NE; Abdelnoor M; Hoffmann P; Eritsland J
    J Am Heart Assoc; 2014 Apr; 3(2):e000679. PubMed ID: 24760962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.
    Meyer GP; Wollert KC; Lotz J; Pirr J; Rager U; Lippolt P; Hahn A; Fichtner S; Schaefer A; Arseniev L; Ganser A; Drexler H
    Eur Heart J; 2009 Dec; 30(24):2978-84. PubMed ID: 19773226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of bone marrow microenvironment on the functional properties of the therapeutic bone marrow-derived cells in patients with acute myocardial infarction.
    Miettinen JA; Salonen RJ; Ylitalo K; Niemelä M; Kervinen K; Säily M; Koistinen P; Savolainen ER; Mäkikallio TH; Huikuri HV; Lehenkari P
    J Transl Med; 2012 Apr; 10():66. PubMed ID: 22462635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of bone marrow cell homing into the infarcted human myocardium.
    Hofmann M; Wollert KC; Meyer GP; Menke A; Arseniev L; Hertenstein B; Ganser A; Knapp WH; Drexler H
    Circulation; 2005 May; 111(17):2198-202. PubMed ID: 15851598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
    Quyyumi AA; Vasquez A; Kereiakes DJ; Klapholz M; Schaer GL; Abdel-Latif A; Frohwein S; Henry TD; Schatz RA; Dib N; Toma C; Davidson CJ; Barsness GW; Shavelle DM; Cohen M; Poole J; Moss T; Hyde P; Kanakaraj AM; Druker V; Chung A; Junge C; Preti RA; Smith RL; Mazzo DJ; Pecora A; Losordo DW
    Circ Res; 2017 Jan; 120(2):324-331. PubMed ID: 27821724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy.
    Miettinen JA; Ylitalo K; Hedberg P; Jokelainen J; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Heart; 2010 Mar; 96(5):362-7. PubMed ID: 19910293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial.
    Schaefer A; Meyer GP; Fuchs M; Klein G; Kaplan M; Wollert KC; Drexler H
    Eur Heart J; 2006 Apr; 27(8):929-35. PubMed ID: 16510465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.
    Afzal MR; Samanta A; Shah ZI; Jeevanantham V; Abdel-Latif A; Zuba-Surma EK; Dawn B
    Circ Res; 2015 Aug; 117(6):558-75. PubMed ID: 26160853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study.
    Lipiec P; Krzemińska-Pakuła M; Plewka M; Kuśmierek J; Płachcińska A; Szumiński R; Robak T; Korycka A; Kasprzak JD
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):587-93. PubMed ID: 19050877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.
    Assmus B; Rolf A; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Tillmanns H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Tonn T; Dimmeler S; Dill T; Zeiher AM; Schächinger V;
    Circ Heart Fail; 2010 Jan; 3(1):89-96. PubMed ID: 19996415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of intracoronary stem cell therapy after acute myocardial infarction.
    Wöhrle J; Merkle N; Mailänder V; Nusser T; Schauwecker P; von Scheidt F; Schwarz K; Bommer M; Wiesneth M; Schrezenmeier H; Hombach V
    Am J Cardiol; 2010 Mar; 105(6):804-12. PubMed ID: 20211323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
    J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarction.
    Davidson SJ; Roncalli J; Surder D; Corti R; Chugh AR; Yang PC; Henry TD; Stanberry L; Lemarchand P; Beregi JP; Traverse JH
    Am Heart J; 2023 May; 259():79-86. PubMed ID: 36796572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.
    Yousef M; Schannwell CM; Köstering M; Zeus T; Brehm M; Strauer BE
    J Am Coll Cardiol; 2009 Jun; 53(24):2262-9. PubMed ID: 19520249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
    Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
    Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
    Janssens S; Dubois C; Bogaert J; Theunissen K; Deroose C; Desmet W; Kalantzi M; Herbots L; Sinnaeve P; Dens J; Maertens J; Rademakers F; Dymarkowski S; Gheysens O; Van Cleemput J; Bormans G; Nuyts J; Belmans A; Mortelmans L; Boogaerts M; Van de Werf F
    Lancet; 2006 Jan; 367(9505):113-21. PubMed ID: 16413875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability.
    Trzos E; Krzemińska-Pakuła M; Rechciński T; Plewka M; Kasprzak J; Peruga JZ; Korycka A; Wierzbowska A; Kurpesa M
    Kardiol Pol; 2009 Jul; 67(7):713-21. PubMed ID: 19649993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.